Keyphrases
Smoking Cessation
42%
Comprehensive Cancer Center
35%
Randomized Clinical Trial
35%
Bupropion
35%
Varenicline
35%
Tobacco Treatment
32%
Nicotine Replacement Therapy
29%
Smoking Cessation Intervention
28%
Treatment Programs
25%
Smokers
25%
Patients with Cancer
20%
Education Model
17%
Treatment Pathways
17%
Community Mental Health Centers
17%
Electronic Cigarette Use
17%
Initial Treatment
17%
Nicotine Patch
17%
Cancer Mortality
17%
Electronic Cigarettes
17%
Treatment Failure
17%
Behavioral Health Needs
17%
Telehealth Delivery
17%
Placebo
17%
Telementoring
17%
Sustained Release
17%
Adverse Events Profile
17%
Major Depressive Disorder
17%
Tobacco Cessation
17%
Consultation Model
17%
Healthcare Professionals
17%
Tobacco Cessation Interventions
17%
Survival Outcomes
17%
Early Intervention
17%
Cancer Diagnosis
17%
Pharmacotherapy
13%
Extension for Community Healthcare Outcomes
13%
Telecare
11%
Tobacco Use
11%
MD Anderson Cancer Center
10%
Cancer Patients
10%
Credible Interval
9%
Medical Needs
8%
Most Common Cause
8%
United States
8%
Mental Health Needs
8%
Current Smokers
8%
Smoking Prevalence
8%
Quitters
8%
Off-label Use
8%
Behavioral Health Care
8%
Medicine and Dentistry
Malignant Neoplasm
100%
Nicotine Withdrawal
88%
Smoking
40%
Varenicline
35%
Randomized Clinical Trial
35%
COVID-19
35%
Abstinence
25%
Counseling
24%
Telehealth
22%
Tobacco Use
19%
Placebo
18%
Drug Therapy
18%
Electronic Cigarette
17%
Health Care Cost
17%
Bupropion
17%
Nicotine Patch
17%
Smoking Cessation Program
17%
Cancer Mortality
17%
Major Depressive Episode
17%
Early Intervention
17%
Cancer Diagnosis
17%
Nicotine Replacement Therapy
12%
Hazard Ratio
10%
Smoke
7%
Prospective Cohort Study
7%
Prevalence
6%
Second Cancer
5%
Patient Referral
5%
Nursing and Health Professions
Nicotine Withdrawal
88%
Malignant Neoplasm
78%
Cancer Center
65%
Community Mental Health Center
35%
Cigarette Filter
32%
Health Care Personnel
17%
Health Care Cost
17%
Smoking Cessation Program
17%
Cancer Mortality
17%
Early Intervention
17%
Cancer Diagnosis
17%
Counseling
17%
Drug Therapy
14%
Prevalence
11%
Hazard Ratio
10%
Prospective Cohort Study
7%
Treatment Outcome
6%
Vulnerable Population
5%
Patient Referral
5%
Clinical Practice
5%
Pandemic
5%
Professional Practice
5%
Population
5%
Telehealth
5%
Chronic Disease
5%
Second Cancer
5%
Cancer Therapy
5%
